Pure Global

Automatic Biochemical Analyzer - Vietnam Registration 2402907ĐKLH/BYT-HTTB

Access comprehensive regulatory information for Automatic Biochemical Analyzer in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2402907ĐKLH/BYT-HTTB and manufactured by Thermo Fisher Scientific Oy. The authorized representative in Vietnam is VĂN PHÒNG ĐẠI DIỆN LIFE TECHNOLOGIES HOLDINGS PTE. LTD. TẠI THÀNH PHỐ HỒ CHÍ MINH.

This page provides complete technical specifications, regulatory compliance details, 5 companies making similar products including LINEAR CHEMICALS, S.L.U, Dirui Industrial Co.,Ltd, and 5 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
5 Competitors
5 Recent Registrations
2402907ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2402907ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Automatic Biochemical Analyzer
VN: Máy xét nghiệm sinh hóa tự động
Risk Class TTBYT Loại C

Registration Details

2402907ĐKLH/BYT-HTTB

000.00.04.G18-240409-0012

Indiko Plus

98640000

Technical Details

Thermo Scientific Indiko Plus Clinical Biochemistry Analyzers are fully automated random access analyzers for routine and special biochemical tests, including specific proteins, therapeutic drugs, and drugs of abuse. Indiko Plus Clinical Biochemistry Analyzers are intended to be used in the diagnosis of disease or other conditions, including the determination of health status, for the purpose of treatment, mitigation, therapy, or prevention of disease. Indiko Plus and all reagents in this system are intended only for in vitro diagnostic use (IVD).

Dates and Status

Oct 22, 2024